Franken, A.; Rivandi, M.; Yang, L.; Jäger, B.; Krawczyk, N.; Honisch, E.; Niederacher, D.; Fehm, T.; Neubauer, H.
A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells. Appl. Sci. 2020, 10, 3364.
https://doi.org/10.3390/app10103364
AMA Style
Franken A, Rivandi M, Yang L, Jäger B, Krawczyk N, Honisch E, Niederacher D, Fehm T, Neubauer H.
A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells. Applied Sciences. 2020; 10(10):3364.
https://doi.org/10.3390/app10103364
Chicago/Turabian Style
Franken, André, Mahdi Rivandi, Liwen Yang, Bernadette Jäger, Natalia Krawczyk, Ellen Honisch, Dieter Niederacher, Tanja Fehm, and Hans Neubauer.
2020. "A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells" Applied Sciences 10, no. 10: 3364.
https://doi.org/10.3390/app10103364
APA Style
Franken, A., Rivandi, M., Yang, L., Jäger, B., Krawczyk, N., Honisch, E., Niederacher, D., Fehm, T., & Neubauer, H.
(2020). A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells. Applied Sciences, 10(10), 3364.
https://doi.org/10.3390/app10103364